Rebiotix raises $25 million in series B

Infectious disease play Rebiotix Inc. (Roseville, Minn.) raised $25 million in a series B round from undisclosed existing and new investors. Rebiotix's RBX2660 is in the Phase II PUNCH CD trial to tre...